Drug development system based on artificial intelligence

Abstract

The invention relates to the technical field of drug research and development, and discloses a drug development system based on artificial intelligence, which comprises a machine intelligent module, an expert intelligent module and a big data platform module, wherein the machine intelligent module is based on AIDD and CADD, and the machine intelligent module comprises a molecule creation unit, a molecule exploration unit, a molecule modification unit, a molecule evaluation unit, a molecule screening unit, a molecule synthesis unit, a molecule interaction unit and a molecule data mining unit. According to the drug development system based on artificial intelligence, based on the AI technology, starting from drug molecules, virtual drug molecules are created and explored through a computer, a big data platform is used for training AI, and molecular structures, characteristics and functions of compounds and possible toxic and side effects are found; molecule screening and structural modification are performed through a machine intelligence, so that drug molecules which are low in toxicity, safe and effective in quality and high in development value are researched and developed, the development success rate of new drugs is increased, and the development cycle of the new drugs is shortened.

Description

technical field [0001] The invention relates to the technical field of drug research and development, in particular to an artificial intelligence-based drug development system. Background technique [0002] Artificial intelligence is an advanced technology that uses the high-speed processing and distributed computing capabilities of computers to simulate the information processing and learning capabilities of the human brain, enabling computers to analyze and solve problems. In order to seize the major strategic opportunities in the development of artificial intelligence and create a first-mover advantage in the development of artificial intelligence, the Chinese government promulgated the "New Generation Artificial Intelligence Development Plan" in July 2017, raising the development of the new generation of artificial intelligence (NGAI) to National strategy; in December of the same year, the Ministry of Industry and Information Technology issued the "Three-Year Action Plan...

AI Technical Summary

Problems solved by technology

[0006] Aiming at the deficiencies of the prior art, the present invention provides a drug development system based on artificial intelligence, which can solve the problems of low development efficiency and long development cycle of the existing traditional drug development system and the existing partial artificial intelligence-based drug development technology There are problems of low drug reliability and accuracy; the present invention, based on AI technology, makes full use of artificial intelligence technology, starts with drug molecules, and has a continuously developed advanced AI drug discovery technology program, which helps to improve the success rate of new drug development and shorten New drug development cycle

Images